An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica FDA to review broader access to restricted peptides in July BPC 157 Banned: Key Facts on the Latest FDA Decision In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to The Peptide Craze Ground Truths